EFTA00665656Set 9
2016-08-256p1,417w
From: Richard Kahn •
To: "Jeffrey E." <jeevacation@gmail.com>
Subject: Re: Add to TEVA and AGN
Date: Thu, 25 Aug 2016 16:43:38 +0000
agreed
her frequent recommendations are reminding ... recommending we add to the two convertible preferred positions we purchased on 8/18
a) teva bought 1,000 @ 901.75 - currently at 883.25 down 2.1% from purchase
b) agn bought ... cell
Begin forwarded message:
EFTA00665656
From: "Ens, Amanda" <
Subject: Add to TEVA and AGN
Date: August 25, 2016 at 9:35:43 AM EDT
To: Richard Kahn c >
Rich,
With
https://www.justice.gov/epstein/files/DataSet%209/EFTA00665656.pdf
EFTA00820341Set 9
2016-08-256p1,243w
From: "Jeffrey E." <jeevacation@grnail.com>
To: Richard Kahn
Subject: Re: Add to TEVA and AGN
Date ... recommending we add to the two convertible preferred positions we purchased on 8/18
a) teva bought 1,000 @ 901.75 - currently at 883.25 down 2.1% from purchase
b) agn bought ... Richard Kahn
HBRK Associates Inc.
Begin forwarded message:
From: "Ens, Amanda"
Subject: Add to TEVA and AGN
Date: August 25, 2016 at 9:35:43 AM EDT
To: Richard Kahn
https://www.justice.gov/epstein/files/DataSet%209/EFTA00820341.pdf
EFTA00820350Set 9
2016-08-256p1,339w
From: "Jeffrey E." <jeevacation@gmail.com>
To: Richard Kahn
Subject: Re: Add to TEVA and AGN
Date: Thu, 25 Aug 2016 16:36:10 +0000
Dumb
On Thursday, 25 August 2016, jeffrey ... recommending we add to the two convertible preferred positions we purchased on 8/18
a) teva bought 1,000 @ 901.75 - currently at 883.25 down 2.1% from purchase
b) agn bought ... HBRK Associates Inc.
tee=
fa
Begin forwarded message:
From: "Ens, Amanda" <
Subject: Add to TEVA and AGN
Date: August 25, 2016 at 9:35:43 AM EDT
To: Richard Kahn
https://www.justice.gov/epstein/files/DataSet%209/EFTA00820350.pdf
EFTA01785499Set 10
2016-08-1519p3,544w
Company bought
$1mm AGN 5.5% 3/1/18 Pfd @ $881.50 (6.2% strip yield) - $0.50 better
$1mm TEVA 7.0% 12/15/18 Pfd @ $901.75 (7.9% strip yield) — same level
Thanks,
Amanda
Amanda Ens
Director
Bank ... Preferreds, thoughts on fixed income, mandatory converts
1 million each of AGN and TEVA
On Mon, Aug 15, 2016 at 7:34 AM, Ens, Amanda > wrote:
Jeffrey,
The account will ... like to proceed with the purchases?
AGN 5.5% 3/1/18 Pfd @ $882.00 (6.2% strip yield)
TEVA 7.0% 12/15/18 Pfd @ $901.75 (7.9% strip yield)
FTR 11.125% 6/29/18 Pfd @ $94.80 (12.0% strip yield
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01785499.pdf
EFTA02454560Set 11
2016-08-1517p3,377w
Preferreds, thoughts on fixed income, mandatory converts
1 million each of AGN and TEVA
On Mon, Aug 15, 2016 a= 7:34 AM, Ens, Amanda > wrote:
Jeffrey,
The account will ... proceed with the purchases?=/u>
AGN 5.5% 3/1/18 Pfd @ $882.00 (6.2% str=p yield)
TEVA 7.0% 12/15/18 Pfd @ $901.75 (7.9% =trip yield)
FTR 11.125% 6/29/18 Pfd @ $94.80 (12.0%=strip yield ... stock is d=wn 25%: -16.2%
QDI-eligible: No</=>
Amount outstanding: $5.06 bn<=u>
TEVA mandatory convert preferred=u>
Ticker: TEVVF Pfd<=p>
Coupon: 7.0%
Maturity: 12/15/2018</=>
Pfd Price
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02454560.pdf
EFTA02454699Set 11
2016-08-1518p3,484w
Preferreds, thoughts on fixed income, mandatory converts
1 million each of AGN and TEVA
On Mon, Aug 15, 2016 at 7:34 AM, Ens, Amanda < <mailto » wrote:
Jeffrey,
The account ... like to proceed with the purchases?
AGN 5.5% 3/1/18 Pfd @ $882.00 (6.2% strip yield)
TEVA 7.0% 12/15/18 Pfd @ $901.75 (7.9% strip yield)
FTR 11.125% 6/29/18 Pfd @ $94.80 (12.0% strip yield ... maturity and stock is down 25%: -16.2%
QDI-eligible: No
Amount outstanding: $5.06 bn
TEVA mandatory convert preferred
Ticker: TEVVF Pfd
Coupon: 7.0%
Maturity: 12/15/2018
Pfd Price: 901.75
TEVA stock
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02454699.pdf
EFTA00702577Set 9
2016-07-282p1,007w
From: Richard Kahn c:I >
To: "jeffrey EI
Subject: Fwd: Allergen and Teva
Date: Thu, 28 Jul 2016 17:47:26 +0000
Wadi merits: agn.pdf; teva.pdf; Cvt_Primer_2013_NEWEST.FDF
!ohne-Images: image0Ol.png ... York. NY 10022
cc
Begin forwarded message:
From: -Ens, Amanda' •z >
Subject: Allergen and Teva
Date: July 28, 2016 at 9:08:09 AM EDT
To: Richard Kahn ‹ >
Rich,
Regarding ... catch-up trade. That said, given your existing exposure, like to suggest AGN and TEVA in specialty pharma. We can also discuss some names in sectors such as med
tech
https://www.justice.gov/epstein/files/DataSet%209/EFTA00702577.pdf
EFTA01737698Set 10
2016-08-0914p2,836w
imaqe006.iPq
imaee007.ioq
imacie008.ipq
imaae009.Mq
imaoe010.Mq
imacie011.clif
Jeffrey,
AGN 5.5% Pfd $886.50 (6.3% strip yield)
TEVA 7.0% Pfd $894.00 (7.9% strip yield)
We could trade today if we can deliver into ... maturity and stock is down 25%: -15.7%
ODI-eligible: No
Amount outstanding: $5.06 bn
TEVA mandatory convert preferred
Ticker: TEVVF Pfd
Coupon: 7.0%
Maturity: 12/15/2018
Pfd Price: 895.07
TEVA stock ... Amanda wrote:
Jeffrey, I continue to like the AGN, TEVA and FTR mandatory convert preferreds. While
AGN missed on sales today, is was mostly due to noise around the last
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01737698.pdf
EFTA01783231Set 10
2016-08-0813p2,785w
maturity and stock is down 25%: -15.7%
MA-eligible: No
Amount outstanding: $5.06 bn
TEVA mandatory convert preferred
Ticker: TEVVF Pfd
Coupon: 7.0%
Maturity: 12/15/2018
Pfd Price: 895.07
TEVA stock ... Amanda <amanda.ens@baml.com <mailto:amanda.ens@baml.com» wrote:
Jeffrey, I continue to like the AGN, TEVA and FTR mandatory convert preferreds. While AGN missed on sales today, is
was mostly due to noise ... around the last minute divestiture of their ANDA distribution business to TEVA. While the
generics sale to TEVA was already built into most analyst models, the ANDA sale
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01783231.pdf
EFTA01783152Set 10
2016-08-0812p2,582w
maturity and stock is down 25%: -15.7%
QDI-eligible: No
Amount outstanding: $5.06 bn
TEVA mandatory convert preferred
Ticker: TEVVF Pfd
Coupon: 7.0%
Maturity: 12/15/2018
Pfd Price: 895.07
TEVA stock ... Amand rote:
Jeffrey, I continue to like the AGN, TEVA and FTR mandatory convert preferreds. While AGN missed on sales today, is
was mostly due to noise around the last ... minute divestiture of their ANDA distribution business to TEVA. While the
generics sale to TEVA was already built into most analyst models, the ANDA sale was not. Revenue thus looks
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01783152.pdf
EFTA02454071Set 11
2016-08-0812p2,677w
maturity =nd stock is down 25%: -15.7%
QDI-eligible: No
Amount outstanding: $5.06=bn
</=>
</=>
TEVA mandatory convert pr=ferred
Ticker: TEVVF Pfd<=>
Coupon: 7.0%
Maturity: 12/15/2018
Pfd Price: 895.07<=>
TEVA ... Amanda
Jeffrey, I continue to=like the AGN, TEVA and FTR mandatory convert preferreds. While AGN missed =n sales
today, is was mostly due to noise around the last minute ... divestiture of their ANDA distribution business to TEVA.
While=the generics sale to TEVA was already built into most analyst models, the =NDA sale was not. Revenue thus looks
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02454071.pdf
EFTA02454468Set 11
2016-08-089p1,838w
Preferreds, thoughts on fixed income, mandatory converts
Jeffrey, I continue to=like the AGN, TEVA and FTR mandatory convert preferreds. While AGN missed =n sales today, is
was mostly ... noise around the last minute divestitu=e of their ANDA distribution business to TEVA. While the
generics sale to TEVA was already built into most analy=t models, the ANDA ... downsi=e profile for holding the mandatory convert vs the common stock.
Allergan, Teva and Frontier Communications ar= three names we have high conviction on and they have mandatory
convert
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02454468.pdf
EFTA01092032Set 9
25p12,760w
PSTI)— $2.98 - Hold
exposed to media, or expanded? The NeoStem product is
Tens Pharmaceuticals (TEVA) - $38.94 - Buy
•Closing prices (7/05/20B) "manipulated." In this report, we review the safety data ... trial strategy is important. Mesoblast is the leader in cardiovascular space. With its
partner Teva, the company is preparing to launch a global phase III program in congestive heart failure ... ability to
regulate inflammation and neoangiogenesis is the best solution. Mesoblast and Teva are planning for a two-
year, $130 million program. Cytori believes it may be possible
https://www.justice.gov/epstein/files/DataSet%209/EFTA01092032.pdf
EFTA00821586Set 9
2016-08-086p2,186w
model. Given the moving parts (generics and
distribution businesses being divested to Teva), there was some 'noise" in the numbers as yaajnantated. That said, we were not too surprised ... thoughts on fixed income, mandatory converts
EFTA00821586
Jeffrey, I continue to like the AGN, TEVA and FTR mandatory convert prefeneds. While AGN missed on sales today, is was mostly ... noise around the last minute divestiture of
their ANDA distribution business to TEVA. While the generics sale to TEVA was already built into most analyst models, the ANDA sale
https://www.justice.gov/epstein/files/DataSet%209/EFTA00821586.pdf